David Reaich

1.2k total citations
22 papers, 822 citations indexed

About

David Reaich is a scholar working on Cell Biology, Physiology and Molecular Biology. According to data from OpenAlex, David Reaich has authored 22 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in David Reaich's work include Muscle metabolism and nutrition (6 papers), Diet and metabolism studies (5 papers) and Metabolism and Genetic Disorders (4 papers). David Reaich is often cited by papers focused on Muscle metabolism and nutrition (6 papers), Diet and metabolism studies (5 papers) and Metabolism and Genetic Disorders (4 papers). David Reaich collaborates with scholars based in United Kingdom, United States and Saudi Arabia. David Reaich's co-authors include Timothy H.J. Goodship, S M Channon, Charles M. Scrimgeour, K. A. Graham, Robert W. Wilkinson, Samantha Downie, Shannon E. Daley, Elizabeth Gilmour, Jutta Paßlick-Deetjen and Meghan E. Murphy and has published in prestigious journals such as The Lancet, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

David Reaich

18 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reaich United Kingdom 11 496 227 202 160 124 22 822
Elizabeth A. Dominic United States 13 300 0.6× 99 0.4× 164 0.8× 190 1.2× 98 0.8× 15 624
W. Kreußer Germany 12 277 0.6× 36 0.2× 108 0.5× 99 0.6× 77 0.6× 49 674
Kinya Hiroshige Japan 9 353 0.7× 27 0.1× 121 0.6× 40 0.3× 113 0.9× 25 612
Jayson Rapoport Israel 13 267 0.5× 31 0.1× 45 0.2× 78 0.5× 147 1.2× 40 601
G Peer Israel 12 213 0.4× 33 0.1× 229 1.1× 59 0.4× 99 0.8× 31 680
Raúl Fernández-Prado Spain 12 237 0.5× 15 0.1× 113 0.6× 161 1.0× 77 0.6× 19 535
Nancy D. Adams United States 13 355 0.7× 25 0.1× 77 0.4× 159 1.0× 68 0.5× 27 768
Junji Takaya Japan 15 115 0.2× 18 0.1× 46 0.2× 111 0.7× 166 1.3× 47 626
E Gautier Switzerland 13 132 0.3× 24 0.1× 81 0.4× 168 1.1× 94 0.8× 41 806
Agostino Mallamace Italy 12 204 0.4× 16 0.1× 71 0.4× 65 0.4× 78 0.6× 27 491

Countries citing papers authored by David Reaich

Since Specialization
Citations

This map shows the geographic impact of David Reaich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reaich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reaich more than expected).

Fields of papers citing papers by David Reaich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reaich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reaich. The network helps show where David Reaich may publish in the future.

Co-authorship network of co-authors of David Reaich

This figure shows the co-authorship network connecting the top 25 collaborators of David Reaich. A scholar is included among the top collaborators of David Reaich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reaich. David Reaich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Jones, Mark, et al.. (2023). NHS staff awareness, attitudes and actions towards the change in organ donation law in England—results of the #options survey 2020. Archives of Public Health. 81(1). 88–88. 4 indexed citations
4.
Kalra, Philip A., Sunil Bhandari, Rachel Davison, et al.. (2020). NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease. BMC Nephrology. 21(1). 539–539. 10 indexed citations
5.
Kalra, Philip A., Sunil Bhandari, Kieran McCafferty, et al.. (2018). SaO001THE NIMO UK STUDY: IS 1000 MG OF INTRAVENOUS IRON ENOUGH TO ACHIEVE HB TARGETS IN PRE-DIALYSIS ANAEMIC PATIENTS?. Nephrology Dialysis Transplantation. 33(suppl_1). i315–i315.
6.
Reaich, David, et al.. (2013). Polyarteritis nodosa presenting with frank hematuria. Canadian Urological Association Journal. 4(6). 172–172.
7.
Unwin, Robert J., et al.. (2012). Truly resistant hypertension?. BMJ Case Reports. 2012. bcr2012007396–bcr2012007396.
8.
Murphy, Meghan E., David Reaich, Pearl Pai, Paul Finn, & Austin Carmichael. (2003). A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. British Journal of Dermatology. 148(2). 314–317. 57 indexed citations
9.
Bartlett, K., et al.. (2002). Effects of feeding on albumin synthesis in hypoalbuminemic hemodialysis patients. Kidney International. 62(1). 266–271. 9 indexed citations
10.
Reaich, David, et al.. (2001). Asymptomatic HIV Patient with Cardiomyopathy and Nephropathy: Case Report and Literature Review. Journal of Infection. 42(4). 288–290. 4 indexed citations
11.
Price, S. Russ, David Reaich, Brian K. England, et al.. (1998). Mechanisms contributing to muscle-wasting in acute uremia. Journal of the American Society of Nephrology. 9(3). 439–443. 34 indexed citations
12.
Reaich, David. (1997). Odour perception in chronic renal disease. The Lancet. 350(9086). 1191–1191. 6 indexed citations
13.
Graham, K. A., David Reaich, S M Channon, Samantha Downie, & Timothy H.J. Goodship. (1997). Correction of acidosis in hemodialysis decreases whole-body protein degradation.. Journal of the American Society of Nephrology. 8(4). 632–637. 162 indexed citations
14.
Reaich, David, et al.. (1996). Correction of acidosis in CAPD decreases whole body protein degradation. Kidney International. 49(5). 1396–1400. 111 indexed citations
15.
Reaich, David, S. Russ Price, Brian K. England, & William E. Mitch. (1995). Mechanisms causing muscle loss in chronic renal failure. American Journal of Kidney Diseases. 26(1). 242–247. 24 indexed citations
16.
Reaich, David, K. A. Graham, S M Channon, et al.. (1995). Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. American Journal of Physiology-Endocrinology and Metabolism. 268(1). E121–E126. 71 indexed citations
17.
Reaich, David, Norman S. Cooper, & John Main. (1994). Rapid Catastrophic Onset of Wegener’s Granulomatosis in a Renal Transplant. ˜The œNephron journals/Nephron journals. 67(3). 354–357. 17 indexed citations
18.
Graham, K. A., David Reaich, & Timothy H.J. Goodship. (1994). Acid-base regulation in peritoneal dialysis.. PubMed. 48. S47–50. 5 indexed citations
19.
Reaich, David, K. A. Graham, Brendan Cooper, Charles M. Scrimgeour, & Timothy H.J. Goodship. (1994). Recovery of 13C in Breath from Infused NaH13CO3 Increases During Euglycaemic Hyperinsulinaemia. Clinical Science. 87(4). 415–419. 3 indexed citations
20.
Reaich, David, S M Channon, Charles M. Scrimgeour, et al.. (1993). Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. American Journal of Physiology-Endocrinology and Metabolism. 265(2). E230–E235. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026